Intellia Therapeutics
NTLA
NTLA
164 hedge funds and large institutions have $1.13B invested in Intellia Therapeutics in 2020 Q2 according to their latest regulatory filings, with 43 funds opening new positions, 58 increasing their positions, 32 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
17% more funds holding
Funds holding: 140 → 164 (+24)
2.78% more ownership
Funds ownership: 92.06% → 94.85% (+2.8%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
164
Holding in Top 10
2
Calls
$5.7M
Puts
$2.52M
Top Buyers
| 1 | +$28.4M | |
| 2 | +$26.5M | |
| 3 | +$24.5M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$18.3M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$16.3M |
Top Sellers
| 1 | -$18.8M | |
| 2 | -$18.2M | |
| 3 | -$3.21M | |
| 4 |
O
OrbiMed
New York
|
-$2.63M |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
-$2.26M |